Michael Gibbs

Michael Gibbs is a Senior Director at AstraZeneca, specializing in clinical development for early oncology. With over 20 years of experience in clinical development and medical affairs, they have led complex clinical trials and evidence generation for large global brands. Michael has held prominent roles across various companies, including Novartis, GSK, and Akela Pharma, where they managed clinical operations, project management, and pharmacovigilance activities. They hold a PhD in Protein Crystallography from the University of Cambridge and a BSc (Hons) in Biochemistry from Bangor University.